Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands):


	Three Months Ended
	April 30, 2026		April 30, 2025

Cost of revenue	$	209	$	231
Sales and marketing		392		703
Research and development		926		1,120
General and administrative		1,972		1,882
Total stock-based compensation expense	$	3,499	$	3,936

As of April 30, 2026, there was $32.7 million of unrecognized compensation expense related to unvested RSUs, stock options and stock purchase rights under the ESPP, which is expected to be recognized over a weighted-average vesting period of approximately 3.0 years.